"The insulin pricing crisis will only be solved when everyone can access and afford insulin," said insulin4all advocate Allison Bailey. (Photo: 2C2KPhotography/flickr/cc)
May 08, 2019
A group of Minnesotans faced with "astronomical prices for insulin" in the U.S. recently crossed the border into Canada to obtain affordable access to the life-saving drug.
"We should not have to drive five hours to Canada to be able to afford #insulin!" said Quinn Nystrom, a diabetes advocate and one of those on the #CaravanToCanada Saturday.
In tweets over the weekend, Nystrom highlighted the price difference the five-hour drive would mean. Insulin costs 10 times more in the U.S. than in Canada.
\u201cSUCCESS! -5-hour road trip. \u2705 -Insulin purchased where NO prescription was needed! \u2705 1 vial of Novolog in the USA \ud83c\uddfa\ud83c\uddf8 = 10 vials of NovoRapid in Canada \ud83c\udde8\ud83c\udde6\u2705 =6 happy & grateful ppl w/type 1 diabetes & T1 Mom\u2019s \ud83d\ude4f\ud83c\udffb\ud83d\udc99#CaravanToCanada #insulin4all #MNinsulin4all\u201d— Quinn Nystrom (@Quinn Nystrom) 1557011340
\u201cA 5 hr road trip & this is the difference in $ for the same product (they just change the name). Where have we gone wrong America?!? We should be ashamed as a country that this is a solvable issue, and nothing has been done to make it more affordable. #insulin4all #MNinsulin4all\u201d— Quinn Nystrom (@Quinn Nystrom) 1557082029
Minneapolis's KARE11 News reported on the caravan.
When the group arrived in Fort Frances, Ontario, they found a pharmacy within a few blocks and were quickly able to pick up everything they needed with no prescription.
"You can see it's the same company," [Travis] Paulson said, comparing two vials, both made by Novo Nordisk.
He purchased NovoRapid in Canada, which retails for about $30. NovoLog, which came from the United States, has a sticker price of about $300.
The caravan-goers' situation drew pity from one Canadian observer.
\u201cAmericans are forming a caravan to travel to Canada to buy affordable insulin. \n\n1\ufe0f\u20e3You are very welcome.\n\n2\ufe0f\u20e3I\u2019m sorry that you need to do this.\n#CaravanToCanada #insulin4all\u201d— Chris Houston (@Chris Houston) 1557005499
The road trip was part of the #insulin4all campaign, which laid out the problem those with Type 1 diabetes face. It noted the following:
- Since the 1990s, the cost of insulin has increased over 1,200%, yet the cost of production for a vial of analog insulin is between $3.69 and $6.16.
- Spending by patients with type 1 diabetes on insulin nearly doubled from 201 to 2016, increasing from $2900 to $5700.
- One of every four patients with type 1 diabetes has had to ration their insulin due to cost. Many have died.
Nystrom has ideas about how to solve the crisis, as ThinkProgress reported:
First, she believes Congress must pass a transparency bill to force pharmaceutical companies to be open about their pricing practices. Several states have taken it upon themselves to pass such legislation. Oregon, for instance, signed a bill into law last year requiring drug makers to report the reasons for price increases, among other requirements.
Second, Nystrom said Congress should follow Minnesota's lead in advancing a federal emergency insulin act that allows someone without insurance to receive an emergency supply of insulin that is needed to survive.
Actions like the #CaravanToCanada, said Allison Bailey, U.S. advocacy manager for T1 International and insulin4all advocate, are "not a long-term solution."
"The insulin pricing crisis will only be solved when everyone can access and afford insulin," she said.
\u201cThe insulin pricing crisis will only be solved when everyone can access and afford insulin. #insulin4all means ALL. And we will only achieve that when every patient in the U.S. can go to their local pharmacy and get the insulin they need for a reasonable price.\u201d— Allison Bailey \ud83d\udd6f\ufe0f (@Allison Bailey \ud83d\udd6f\ufe0f) 1557264033
To make that happen, said political commentator Robert Reich, "We must allow the government to negotiate lower prices."
"Amen," replied caravan participant Lija Greenseid.
An Unconstitutional Rampage
Trump and Musk are on an unconstitutional rampage, aiming for virtually every corner of the federal government. These two right-wing billionaires are targeting nurses, scientists, teachers, daycare providers, judges, veterans, air traffic controllers, and nuclear safety inspectors. No one is safe. The food stamps program, Social Security, Medicare, and Medicaid are next. It’s an unprecedented disaster and a five-alarm fire, but there will be a reckoning. The people did not vote for this. The American people do not want this dystopian hellscape that hides behind claims of “efficiency.” Still, in reality, it is all a giveaway to corporate interests and the libertarian dreams of far-right oligarchs like Musk. Common Dreams is playing a vital role by reporting day and night on this orgy of corruption and greed, as well as what everyday people can do to organize and fight back. As a people-powered nonprofit news outlet, we cover issues the corporate media never will, but we can only continue with our readers’ support. |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
A group of Minnesotans faced with "astronomical prices for insulin" in the U.S. recently crossed the border into Canada to obtain affordable access to the life-saving drug.
"We should not have to drive five hours to Canada to be able to afford #insulin!" said Quinn Nystrom, a diabetes advocate and one of those on the #CaravanToCanada Saturday.
In tweets over the weekend, Nystrom highlighted the price difference the five-hour drive would mean. Insulin costs 10 times more in the U.S. than in Canada.
\u201cSUCCESS! -5-hour road trip. \u2705 -Insulin purchased where NO prescription was needed! \u2705 1 vial of Novolog in the USA \ud83c\uddfa\ud83c\uddf8 = 10 vials of NovoRapid in Canada \ud83c\udde8\ud83c\udde6\u2705 =6 happy & grateful ppl w/type 1 diabetes & T1 Mom\u2019s \ud83d\ude4f\ud83c\udffb\ud83d\udc99#CaravanToCanada #insulin4all #MNinsulin4all\u201d— Quinn Nystrom (@Quinn Nystrom) 1557011340
\u201cA 5 hr road trip & this is the difference in $ for the same product (they just change the name). Where have we gone wrong America?!? We should be ashamed as a country that this is a solvable issue, and nothing has been done to make it more affordable. #insulin4all #MNinsulin4all\u201d— Quinn Nystrom (@Quinn Nystrom) 1557082029
Minneapolis's KARE11 News reported on the caravan.
When the group arrived in Fort Frances, Ontario, they found a pharmacy within a few blocks and were quickly able to pick up everything they needed with no prescription.
"You can see it's the same company," [Travis] Paulson said, comparing two vials, both made by Novo Nordisk.
He purchased NovoRapid in Canada, which retails for about $30. NovoLog, which came from the United States, has a sticker price of about $300.
The caravan-goers' situation drew pity from one Canadian observer.
\u201cAmericans are forming a caravan to travel to Canada to buy affordable insulin. \n\n1\ufe0f\u20e3You are very welcome.\n\n2\ufe0f\u20e3I\u2019m sorry that you need to do this.\n#CaravanToCanada #insulin4all\u201d— Chris Houston (@Chris Houston) 1557005499
The road trip was part of the #insulin4all campaign, which laid out the problem those with Type 1 diabetes face. It noted the following:
- Since the 1990s, the cost of insulin has increased over 1,200%, yet the cost of production for a vial of analog insulin is between $3.69 and $6.16.
- Spending by patients with type 1 diabetes on insulin nearly doubled from 201 to 2016, increasing from $2900 to $5700.
- One of every four patients with type 1 diabetes has had to ration their insulin due to cost. Many have died.
Nystrom has ideas about how to solve the crisis, as ThinkProgress reported:
First, she believes Congress must pass a transparency bill to force pharmaceutical companies to be open about their pricing practices. Several states have taken it upon themselves to pass such legislation. Oregon, for instance, signed a bill into law last year requiring drug makers to report the reasons for price increases, among other requirements.
Second, Nystrom said Congress should follow Minnesota's lead in advancing a federal emergency insulin act that allows someone without insurance to receive an emergency supply of insulin that is needed to survive.
Actions like the #CaravanToCanada, said Allison Bailey, U.S. advocacy manager for T1 International and insulin4all advocate, are "not a long-term solution."
"The insulin pricing crisis will only be solved when everyone can access and afford insulin," she said.
\u201cThe insulin pricing crisis will only be solved when everyone can access and afford insulin. #insulin4all means ALL. And we will only achieve that when every patient in the U.S. can go to their local pharmacy and get the insulin they need for a reasonable price.\u201d— Allison Bailey \ud83d\udd6f\ufe0f (@Allison Bailey \ud83d\udd6f\ufe0f) 1557264033
To make that happen, said political commentator Robert Reich, "We must allow the government to negotiate lower prices."
"Amen," replied caravan participant Lija Greenseid.
A group of Minnesotans faced with "astronomical prices for insulin" in the U.S. recently crossed the border into Canada to obtain affordable access to the life-saving drug.
"We should not have to drive five hours to Canada to be able to afford #insulin!" said Quinn Nystrom, a diabetes advocate and one of those on the #CaravanToCanada Saturday.
In tweets over the weekend, Nystrom highlighted the price difference the five-hour drive would mean. Insulin costs 10 times more in the U.S. than in Canada.
\u201cSUCCESS! -5-hour road trip. \u2705 -Insulin purchased where NO prescription was needed! \u2705 1 vial of Novolog in the USA \ud83c\uddfa\ud83c\uddf8 = 10 vials of NovoRapid in Canada \ud83c\udde8\ud83c\udde6\u2705 =6 happy & grateful ppl w/type 1 diabetes & T1 Mom\u2019s \ud83d\ude4f\ud83c\udffb\ud83d\udc99#CaravanToCanada #insulin4all #MNinsulin4all\u201d— Quinn Nystrom (@Quinn Nystrom) 1557011340
\u201cA 5 hr road trip & this is the difference in $ for the same product (they just change the name). Where have we gone wrong America?!? We should be ashamed as a country that this is a solvable issue, and nothing has been done to make it more affordable. #insulin4all #MNinsulin4all\u201d— Quinn Nystrom (@Quinn Nystrom) 1557082029
Minneapolis's KARE11 News reported on the caravan.
When the group arrived in Fort Frances, Ontario, they found a pharmacy within a few blocks and were quickly able to pick up everything they needed with no prescription.
"You can see it's the same company," [Travis] Paulson said, comparing two vials, both made by Novo Nordisk.
He purchased NovoRapid in Canada, which retails for about $30. NovoLog, which came from the United States, has a sticker price of about $300.
The caravan-goers' situation drew pity from one Canadian observer.
\u201cAmericans are forming a caravan to travel to Canada to buy affordable insulin. \n\n1\ufe0f\u20e3You are very welcome.\n\n2\ufe0f\u20e3I\u2019m sorry that you need to do this.\n#CaravanToCanada #insulin4all\u201d— Chris Houston (@Chris Houston) 1557005499
The road trip was part of the #insulin4all campaign, which laid out the problem those with Type 1 diabetes face. It noted the following:
- Since the 1990s, the cost of insulin has increased over 1,200%, yet the cost of production for a vial of analog insulin is between $3.69 and $6.16.
- Spending by patients with type 1 diabetes on insulin nearly doubled from 201 to 2016, increasing from $2900 to $5700.
- One of every four patients with type 1 diabetes has had to ration their insulin due to cost. Many have died.
Nystrom has ideas about how to solve the crisis, as ThinkProgress reported:
First, she believes Congress must pass a transparency bill to force pharmaceutical companies to be open about their pricing practices. Several states have taken it upon themselves to pass such legislation. Oregon, for instance, signed a bill into law last year requiring drug makers to report the reasons for price increases, among other requirements.
Second, Nystrom said Congress should follow Minnesota's lead in advancing a federal emergency insulin act that allows someone without insurance to receive an emergency supply of insulin that is needed to survive.
Actions like the #CaravanToCanada, said Allison Bailey, U.S. advocacy manager for T1 International and insulin4all advocate, are "not a long-term solution."
"The insulin pricing crisis will only be solved when everyone can access and afford insulin," she said.
\u201cThe insulin pricing crisis will only be solved when everyone can access and afford insulin. #insulin4all means ALL. And we will only achieve that when every patient in the U.S. can go to their local pharmacy and get the insulin they need for a reasonable price.\u201d— Allison Bailey \ud83d\udd6f\ufe0f (@Allison Bailey \ud83d\udd6f\ufe0f) 1557264033
To make that happen, said political commentator Robert Reich, "We must allow the government to negotiate lower prices."
"Amen," replied caravan participant Lija Greenseid.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.